Targeting CD44 receptor-positive lung tumors using polysaccharide-based nanocarriers: Influence of nanoparticle size and administration route.
暂无分享,去创建一个
J. Coll | V. Josserand | A. Hurbin | S. Lecommandoux | C. Schatz | S. Mazzaferro | Victor Jeannot | M. Henry | Laetitia Vanwonterghem | J. Vollaire | J. Lavaud | M. Arboléas